In this issue of the journal, Mutch et at t report the results of a randomized prospective trial comparing two anaesthetic regimens (isoflurane versus propofol) in the management of patients undergoing carotid endarterectomy (CAE). The study focused specifically on the cardiovascular effects of intraoperative-induced hypertension. The principal outcome measures were haemodynamic instability (blood pressure or heart rate <80% or >120% of ward values) and myocardial ischaemia (ST segment depression _>0.1 mV persisting for _>1 min). Intraoperative haemodynamic management differed between the two groups, with the isoflurane group receiving a larger total phenylephrine dose and more isoflurane patients requiring vasodilator therapy on emergence. With these measures, intraoperative haemodynamic stability was similar in the two groups. No patient showed Holter evidence of myocardial ischaemia intraoperatively. During emergence from anaesthesia, the isoflurane patients were hypertensive for a greater proportion of the time. More patients in the isoflurane group (7/13) had Holter monitor evidence of myocardial ischaemia than in the propofol group (3/14, P = 0.029). In this study the period of greatest risk for myocardial ischaemia was during emergence from anaesthesia, when haemodynamic instability was more frequent. These results would support the view that haemodynamic factors are major determinants of myocardial ischaemia during the perioperative period. Thus, this opinion would hold, as long as the haemodynamic state of the patient is tightly controlled, arterial hypertension may be induced without producing myocardial ischaemia. Before accepting this approach, we should examine some previous observations concerning carotid surgery, myocardial ischaemia, and adverse cardiac outcomes.
Editorial
The choice of anaesthetic for carotid endarterectomy: does it matter?
David P. Archer MD MSe FRCPC, Timothy K.K. Tang MD FRCPC In this issue of the journal, Mutch et at t report the results of a randomized prospective trial comparing two anaesthetic regimens (isoflurane versus propofol) in the management of patients undergoing carotid endarterectomy (CAE). The study focused specifically on the cardiovascular effects of intraoperative-induced hypertension. The principal outcome measures were haemodynamic instability (blood pressure or heart rate <80% or >120% of ward values) and myocardial ischaemia (ST segment depression _>0.1 mV persisting for _>1 min). Intraoperative haemodynamic management differed between the two groups, with the isoflurane group receiving a larger total phenylephrine dose and more isoflurane patients requiring vasodilator therapy on emergence. With these measures, intraoperative haemodynamic stability was similar in the two groups. No patient showed Holter evidence of myocardial ischaemia intraoperatively. During emergence from anaesthesia, the isoflurane patients were hypertensive for a greater proportion of the time. More patients in the isoflurane group (7/13) had Holter monitor evidence of myocardial ischaemia than in the propofol group (3/14, P = 0.029). In this study the period of greatest risk for myocardial ischaemia was during emergence from anaesthesia, when haemodynamic instability was more frequent. These results would support the view that haemodynamic factors are major determinants of myocardial ischaemia during the perioperative period. Thus, this opinion would hold, as long as the haemodynamic state of the patient is tightly controlled, arterial hypertension may be induced without producing myocardial ischaemia. Before accepting this approach, we should examine some previous observations concerning carotid surgery, myocardial ischaemia, and adverse cardiac outcomes.
Carotid endarterectomy has the distinction of being, in terms of mortality and morbidity, one of the best charFrom the Department of Anaesthesia, University of Calgary, Calgary, Alberta acterized surgical procedures. CAE has the advantage that the major perioperative morbid events (cerebral and cardiac ischaemia and infarction) have clearly defined characteristics. For those who wish to evaluate treatments, the major disadvantage is that these adverse outcomes occur with low frequency. In patients not stratified for cardiac risk, mortality attributable to cardiac ischaemic events is approximately 2%. 2 Let us assume that a 50% increase in perioperative cardiac mortality due to a treatment such as induced hypertension would be clinically significant. Further, let us analyse the results if such a treatment effect were present in the entire patient population of the North American Symptomatic Carotid Endarterectomy Trial (NASCET).: As shown in the Table, such an effect would not be detected -a total sample size of nearly 9000 patients would be required to be 80% certain of showing the difference. When patients are stratified according to the Goldman Index, 3 the perioperafive mortality rate for individuals in classes III and IV (9%), is much greater in classes I and II (1%). 4 Even with this higher mortality rate, the estimated sample size required to detect 50% increase (to 14.1%) in mortality due to treatment is 1400 patients. In a trial the size of NASCET, the perioperative mortality rate among Goldman class III and IV patients would have to double to ensure detection. Perioperative stroke rates are similar to or less than rates of cardiac ischaemic events; the difficulties of demonstrating benefit or increased risk from techniques such as induced hypertension are consequently formidable.
It is therefore easy to understand why, in a study of this size, Mutch et al. used myocardial ischaemia as their main cardiac outcome measure rather than myocardial infarction or other ischaemic events. Unfortunately, although myocardial ischaemia is undesirable, we cannot at present estimate the actual impact on patient wellbeing if the episode is short-lived. Only a small minority (~7%) of patients with postoperative myocardial ischae-9 mia progress to cardiac death, nonfatal myocardial in- farction, or unstable angina. 3 To make matters worse, 50% of these ischaemic events occur on postoperative days 2-5, 5 a time during which most patients have left or are preparing to leave the intensive care unit. We cannot rely on the patients to warn us when they have myocardial ischaemia, because 97% of them are asymptomatic. 5 The results of the present study offer the possibility that the period of haemodynamic instability during and following emergence from anaesthesia coincides with the period of greatest risk for cardiac ischaemia and subsequent adverse cardiac outcomes. Carotid endarterectomy is a relatively superficial procedure and may not involve such marked changes in fluid balance, respiratory function, and pain perception as accompany more invasive surgery. It is therefore quite plausible that CAE may not be associated with a high frequency of cardiac events after the ftrst postoperative day. 5 A retrospective study supports this hypothesis. 6 It would be appropriate for a large prospective study to include a determination of the risk of myocardial ischaemia and adverse cardiac outcomes on each day of the immediate postoperative period. At present, these observations should remind us our patients deserve the same level of vigilance for haemodynamic stability during emergence and recovery from anaesthesia as we offer intraoperatively. In contrast to a previous report, 7 induced hypertenison in the present study was not associated with myocardial ischaemia. As discussed by the authors, this may have been due to difference in the sensitivity of the techniques used to detect myocardial ischaemia in the two studies. It is also possible that the severity of coronary artery disease differed between the two studies. In retrospective study, Musser et al, 4 showed that CAE patients in Goldman Cardiac Risk Classes I and II were at much lower risk (1.1%) for myocardial infarction that patients in Classes III and IV (12.5%, P = 0.0001). To assess this issue in future, consideration should be given to prospective classification of patients according to cardiac functional class and a cardiac risk index.3 Can we be reassured by the present results? Our feeling is that we should assess carefully the cardiac functional status of our patients preoperatively and monitor appropriately during the perioperative period. In this way any adverse effects of induced hypertension on the heart will be detected as soon as possible and corrective therapy provided. When assessing the risks and benefits of induced hypertension it is important to recall that although the frequency of haemodynamic stroke during carotid endarterectomy has not been precisely defined, it makes up only 10% of patients with acute ischaemic stroke. 8 These patients appear to be at high risk, both for further pefioperative cerebral ischaemic events and for myocardial infarction. 8 For the majority of patients, not a risk for haemodynamic stroke, the benefits of induced hypertension have not been established.
The difference in the emergence characteristics of patients between the isoflurane-and propofol-based anaesthetic regimens is a very interesting observation. Emergence is a complex process during which the effects of subhypnotic concentrations of anaesthetics upon cardiorespiratory control and pain perception interact with environmental and corporal stimuli. We already have several hints that the emergence period is a dynamic and changing interaction between the resposiveness of the nervous system and the stimuli which it is processing. Level of consciousness is proposed to be an important determinant of the effects of subanaesthetic concentrations on ventilatory control. 9 Pain perception is accentuated at subhypnotic concentrations of many anaesthetics. ~0 Further study will be required to determine the factors which are important to haemodynamic control during emergence from anaesthesia. We cannot tell whether the differences between isoflurane and propofol observed in the present study were due to the pharmacological properties of the drugs themselves or other characteristics of the emergence states such as the rate of emergence or the duration that subhypnotic anaesthetic concentrations were maintained.
The immediate postoperative period is dearly a complex and perhaps dangerous time for patients with coronary artery disease. Tight haemodynamic control during this period is likely to be even more demanding (and much more cosily) than during induction. It is essential that the risks during this period be carefully evaluated in trials large enough to enable the use of more meaningful outcome measures such as the incidence of myocardial infarction, or congestive heart failure or ICU stay.
Pour l'endart6rectomle carotidienne, le choix de l'agent anesth6sique est-il important?
Ce
ils se sont int6ress6s ~ Hnstabilit6 h6modynamique (pression art6rielle ou fr6quence eardiaque <80% ou >120% des valeurs initiales) et l'iseh6mie myoeardique (d6pression du segment ST > 0,I mV pendant 1 min). Entre les deux groupes, la gestion h6modynamique perop6ratoire diff6re de la fa~on suivante: le groupe isoflurane a dfi recevoir une dose plus importante de ph6nyl6phrine et plus de patients de ce groupe ont eu besoin de vasodilatateurs fi la phase du r6veil. Pour les param6tres choisis, la stabilit6 perop6m-toire a 6t6 la mSme pour les deux groupes. Aucun patient n'a pr6sent6 d'isch6mie myocardique d6celable par le moniteur de Holter. Pendant la phase d'6mergence, les patients du groupe isoflurane ont 6t6 hypertendus pendant plus longtemps. Dam le groupe isoflurane, un plus grand nombre de patients (7/13) a pr6sent6 de l'isch6mie myoeardique d6celable par le moniteur de Holter que dans le groupe propofol (3/14, P = 0,029). Au eours de cette &ude, la p6riode de risque d'isch6mie myocardique 6tait la phase d'6mergence de ranesth6sie pendant laquelle ILnstabilit6 h6modynamique survenaJt plus fr6quemment. Ces donn6es favorisent la th6orie qui d6signe les facteurs h6modynamique comme d6terminants majeurs de l'isch6-mie myocardique ~t la p6riode p6riop6ratoire. On pourrait donc en d&luire qu'en autant que l'h6modynamique est eontr616e de pros, laaypertension art6rielle d61ib6r6e peut 8tre r6alis6e sans isch6mie myoeardique. Avant d'accepter cette hypoth6se, nous devons examiner les 6tudes qui se sont int6ress6es ~t la ehirurgie de la carotide, ~t riseh6mie myocardique et aux r6percussions cardiaques nocives.
L'endart6rectomie earotidienne poss&ie cette distinction d'etre, parmi les interventions ehirurgicales, une des rnieux caract&is6es en terme de mortalit6 et de morbidit6. Cette intervention a la particularit6 de pr6senter une morbidit6 p~riop6mtoire (infarctus, iseh6mie cardiaque et une population identique h celle du relev6 nordam6ricain sur l'endart6rectomie carotidenne symptomatique (NASCET). 2 Comme le montre le Tableau, cet effet ne serait pas d6tect6 -un 6chantillonnage de pr6s de 9000 patients 6tants requis pour pouvoir d6montrer une diff6rence caract6fis6e par un degr6 de certitude de 80%. Quand les patients sont r6partis conform6ment A l'indice de Goldman, 3 le taux de mortalit6 p6riop6rtoire pour les sujets de classe III et IV (9%) est beaucoup plus 61ev6 que pour les classes Iet II (1%). MHme avec ce taux plus 61ev6 de mortalit6, l'estim6 de grandeur de l'6chan-tillon requis pour d6tecter une augmentation de 50% (A 14,1%) de la mortalit6 caus6e par une intervention pharmacologique n6cessite 1400 patients. Dans un relev6 eomme celui de NASCET, le taux de mortalit6 p6rio-p6ratoire pour les patients des classes Goldman III et IV devrait doubler pour pouvoir 6tablir une relation de cause ~ effet. Quant~ Kncidence p6riop6ratoire de l'aceident c6r6brovaseulaire (ACV), ere est identique ou moins 61ev6e que le taux d~eh6mie eardiaque; d6montrer le b6n6fice ou le risque suscit6 par une technique comme l'hypertemion d61ib6r6e constitue, par com6quence, un obstacle redoutable.
I1 est done facile eomprendre pourquoi, dans une 6tude de cette taille, Mutch et aL ont utilis6 l'isch6mie myocardique plut6t que l'infarctus du myocarde ou tout autre incident d'ordre iseh6mique pour pond6rer leurs r6sultats. Malheureusement, malgr6 le fait l'isch6mie soit un 6v6ne-ment ind6sirable, nous ne pouvons pr6sentement en 6va-luer l'impact sur le bien-~tre de patient en bon 6tat si l'tpisode est de courte durte. Seulement une minorit6 (~-7%) des patients qui ont prtsent6 de l'isch~mie postoptratoire, 6volue vers l'infarctus non fatal, l'angine instable ou dtc~dent. 5 Pour compliquer les choses, 50% de ces incidents ischtmiques surviennent entre la deuxi~me et la cinqui~me journte postoptratoire, 5 alors que la plupart des patients ont quitt6 ou s'apprStent ~ quitter runite de soins intensifs. On ne pent ~videmment passe tier non plus aux patients pour nous pr~venir quand ils prtsentent de l'ischtmie cardiaque parce que dans 97% des cas elle est asymptomatique. 5 Les rtsultats de la prtsente 6tude suggtrent que la ptriode d'instabilit6 htmodynamique qui survient pendant et apr~s l'~mer-gence de ranesthtsie coincide avec la p~roide de risque maximal d'ischtmie c ar~aque suivie de ses consequences n~fastes. L'endart6rectornie carotidienne constitue une intervention de surface et ne provoque pas, en gtntral, d'alttrations importantes de l'tquilibre hydrique, de la fonction respiratoire et de la perception douloureuse comme le ferait une ehirurgie plus effractive. I1 est done tr~s plausible que lq~AC ne s'associe pas /~ une incidence 61evte d'tv~nements cardiaques apr~s la premiere journte du postoptratoire. 5 Une 6rude rttrospeetive supporte cette hypoth~se. 6 I1 serait pertinent de dtterminer sur une grande 6chelle et fagon prospective le risque d'ischtmie myocardique et l'tvolution cardiaque dtfavorble pour chacun des jours de la p~riode postop~ratoire immtdiate. Pour le moment, ces observations devraient au moins nous rappeler que nos patients mtritent le mSme niveau de surveillance htmodynamique pendant l'tmergnece et le rtveil que pendant l'intervention.
Contrairement/t un travail ant&ieur,7 dans l'~tude actuelle, l~aypertension d61ibtrte n'est pas associte ~ l~sch~-mie cardiaque. Comme le font remarquer les auteurs, ceci pourrait 8tre df~ /t la difftrence de sensibilit~ des teehnques de dtteetion de l'ischtmie myocardique choisies pour les deux ~tudes. I1 est aussi possible que la gravit6 de la maladie coronaire ait diff~rt. Dans leur 6tude rttrospective, Musser et al. 4 ont montr6 que les candidats /t rEAC classts Iet II sur l'tchelle de Goldman 6taient beaucoup moins/~ risque (1,1%) d'infarctus du myocarde que les patients de classes III et IV (12,5%, P = 0,0001). A ravenir, pour 6valuer cet aspect, il faudrait songer classer les patients prospectivement selon leur fonction cardiaque et leur assigner une cote de risque cardiaque. 3 Est-c,e que les rtsultats aetuels sont rassurants? Nous avons l'impression que nous devrions 6valuer le status cardiaque fontionnel de nos patients et les monitorer en constquence pendant la p6riode p~rioptratoire. De cette fa~on, les effets cardiaque nuisibles de l~nypertension d~li-btrte nous seront r~vtlts plus prtcocement et nous pourrons entreprendre le traitement sans tarder. En 6valuant les risques et les btntfices de l'hypertension dtlibtr~e, il est importante de se rappeler que bien que, pendant I~EAC, la frtquence de rACV d'origine htmodynamique n'ait pas 6t6 dtterminte avec prtcision, die ne reprtsente que 10% des ACV d'origine ischtmique. 8 Ces patients comporteraient un risque 61ev6 d'accidents ptrioptratoires etrtbraux ischtmiques ulttrieurs et d~nfarctus du myoearde. 8 Pour la plupart des patients qui ne sont pas /t risque d'un ACV htmodynamique, les btntfices de l~ay-pertension dtlibtrte n'ont pas 6t6 6tablis.
La difftrence entre les caracttristiques d'tmergence des patients sous anesthtsie ~ base d'isoflurane et de propofol prtsente un inttrSt particulier. L'tmergence constitue un processus complexe pendant lequel les rtpercussions des concentrations sous-hypnotiques d'anesthtsiques sur le contrble cardiorespiratoire et la perception douloureuse interagissent avec les stimuli environnementaux et les stimuli somatiques. Nous poss&lons dtjA de bonnes indications qui sugg&ent que l'tmergence reprtsente une interaction dynamique et variable entre la rtponse du syst~me nerveux central et les stimuli qu'il transforme. Le niveau du conscience pourrait constituer un dtterminant important des effets des concentrations sous-anesthtsiques sur le contr61e de la ventilation. 9 La perception de la douleur est intensifite par les concentration sousanesthtsiques de plusieurs agents. 10 De nouvelle &udes seront requises pour d&erminer quels facteurs, pendant l'tmergence de l'anesthtsie, sont importants pour le contrfle htmodynamique. Nous ne pouvons affu'mer que les difftrences entre l'isoflurane et le propofol rapporttes ici sont dues aux caracttristiques pharmacologiques des agents ou /t d'autres caract~ristiques de l'tmergence comme la rapidit6 ou la durC~e de l'entretien avec des agents en concentrations sous-hypnotiques.
Le postop~ratoire immtdiat est certes une ptriode complexe et peut-~tre mSme dangereuse pour les coronariens. Pendant cette phase, un contr61e htmodynamiques rigoureux risque d'Stre plus astreignant (et beaucoup plus dispendieux) que pendant Fmduction. I1 est essentiel d'tvaluer mtticuleusement pendant cette ptriode les risques avec des 6tudes assez vastes pour permettre l'utilisation de mesures valides des rtsultats comme rincidence de l'infarctus du myocarde, ILnsufftsance eardiaque globale ou la durte de stjour ~ lkmit6 de soins intensifs.
